A series of linear aliphatic diamine-based benzoxazine monomers has been polymerized into transparent, crosslinked specimens that are free of voids and have good mechanical integrity. The density of these polybenzoxazines is measured as a function of the amine chain length. Dynamic mechanical analysis of these linear aliphatic polybenzoxazines shows two, chain length dependent transitions. Properties, such as room temperature modulus, glass transition temperature, crosslink density, thermal degradation temperature, and char yield, of the polybenzoxazines are investigated as a function of the chain length. All these properties exhibit strong dependence on the chain length. These aliphatic amine-based polybenzoxazines are found to be much more flexible than the bisphenol-type polybenzoxazines.
ABSTRACT:The effect of temperature on hydrogen bonding was investigated by measuring the integrated infrared absorbance of various hydrogen-bonding modes as a function of temperature. It was found that conformationally preferred hydrogenbonding modes maintain constant intensities over the wide temperature ranges studied for both polybenzoxazines and a novolac-type phenolic resin. In particular, the O---H---N hydrogen bond shows strong bonding that does not change over the temperature range. On the other hand, statistically distributed hydrogen bonding is more sensitive to the temperature change and its infrared intensities start decreasing around the -transition of polybenzoxazines. The unusual physical and mechanical properties of polybenzoxazines, including volumetric expansion upon polymerization, high moduli, and high glass transition temperatures, are explained based on the complex hydrogen bonding.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.